Over 450 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions. Over 80 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing.
Topics: Proteins, antibodies, bispecifics